GoldenGolden
Advanced Search
Caxton Advantage Life Sciences Fund

Caxton Advantage Life Sciences Fund

A venture capital and private equity firm investing in companies operating in the life science industry.

All edits by  Dawson Sewell 

Edits on 3 Feb, 2020
Dawson Sewell
Dawson Sewell edited on 3 Feb, 2020
Edits made to:
Infobox (+1 properties)
Description (+105 characters)
Article (+512 characters)
Topic thumbnail

Caxton Advantage Life Sciences Fund

A venture capital and private equity firm investing in companies operating in the life science industry.

Article

Caxton Advantage Life Sciences Fund is a venture capital and private equity firm investing in companies operating in the life science industry that is headquartered in New York City, New York.

Investments

Caxton Advantage Life Sciences Fund has made 13 investments, 5 lead investments, and 5 exits. Notable investments made by the firm include: Sunesis Pharmaceuticals (exit), Anthera Pharmaceuticals (exit), Regado Biosciences (exit), Gemi X Pharmaceuticals (exit), Corthera (exit), and Mevion Medical Systems.

Infobox
Location
New York City
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.